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We read with interest the study in CMI by
Wroblewska et al. [1], which reported the identiﬁ-
cation of a VIM-type metallo-b-lactamase (MBL)
determinant in Acinetobacter baumannii in Poland.
Resistance to carbapenems in Acinetobacter spp. is
increasingly reported worldwide and is associated
with various resistance mechanisms, but mostly
with the expression of carbapenemases [2]. Carb-
apenem-hydrolysing class D b-lactamases are
widespread and have been identiﬁed worldwide
in Acinetobacter spp., whereas MBLs are much less
prevalent in this genus [3]. VIM-2-producing Aci-
netobacter spp. have been isolated in the Far East [4]
and in Germany [5], while the VIM-1 determinant
has been reported only once in A. baumannii in
Greece [6]. VIM-4 is a point mutant of VIM-1 and
has previously been identiﬁed only in Enterobac-
teriaceae [7] and Pseudomonas spp. [8]. We now
wish to report the identiﬁcation of the VIM-4 MBL
determinant in Acinetobacter genomospecies 16.
Twenty-two carbapenem-resistant clinical iso-
lates of Acinetobacter spp. were collected between
2001 and 2006 at the Papageorgiou General
Hospital, Thessaloniki, Greece. Since there is an
increasing incidence of MBL determinants among
enterobacterial [9] and Pseudomonas aeruginosa
isolates in Greece [10], we aimed to evaluate their
possible spread among Acinetobacter spp. The
isolates were characterised using phenotypic
(ATB 32 GN and Vitek 2 systems; bioMe´rieux,
Marcy-l’Etoile, France) and genotypic (16S rRNA
gene sequencing [11]) approaches. Imipenem
susceptibility was determined using the disk-
diffusion technique (http://www.sfm.fr) and
antibiotic disks from Sanoﬁ-Diagnostics Pasteur
(Marnes-La-Coquette, France). The production of
MBL was evaluated using the imipenem-EDTA
Etest synergy test as recommended by the man-
ufacturer (AB Biodisk, Solna, Sweden). A single
isolate, Acinetobacter sp. 154, yielded a positive
MBL test. This isolate was resistant to ceftazidime
(MIC 256 mg ⁄L), imipenem (MIC 32 mg ⁄L) and
meropenem (MIC 32 mg ⁄L), but was susceptible
to amoxycillin–clavulanate and ticarcillin–clavul-
anate combinations, and also to aztreonam. In
addition, isolate 154 was resistant to chloramphe-
nicol, sulphonamides, amikacin and kanamycin,
but was susceptible to gentamicin, nalidixic acid,
ﬂuoroquinolones, rifampicin and tetracycline.
Production of extended-spectrum b-lactamase
was evaluated using a double-disk synergy test
[12], with negative results.
Isolate 154 was from the sputum of a patient
aged 80 years who was hospitalised in the inter-
nal medicine ward. Whole-cell DNA of Acineto-
bacter sp. isolate 154 was tested by PCR using
primers speciﬁc for blaIMP and blaVIM [13], giving
rise to a blaVIM-positive amplicon. Sequencing
performed using a GeneAmp PCR system 9700
(AB Applied Biosystems, Foster City, CA, USA)
revealed that isolate 154 possessed blaVIM-4. PCR
combinations using the 5¢-CS, 3¢-CS and blaVIM
primers [14] revealed that blaVIM-4 was part of a
class 1 integron, being the second gene cassette
after the aacA4 gene encoding the AAC(6¢)-Ib
acetyltransferase. In order to determine the exact
location of the blaVIM-4-containing integron, an
I-CeuI-restriction experiment was performed [15];
this revealed that the blaVIM-4 gene was chromo-
somally located (Fig. 1). No additional blaOXA-23,
blaOXA-40, blaOXA-58 or blaOXA-51-type carbapenem-
ase genes were present in isolate 154 according to
the results of PCR assays [16].
Precise identiﬁcation of isolate 154 to the spe-
cies level using a genotypic approach revealed that
this strain belonged to Acinetobacter genomospe-
cies 16, and not to A. baumannii, as was suggested
by initial identiﬁcation results based on the use of
biochemical techniques. This result was in accord
with the failure to detect the intrinsic blaOXA-51-like
gene of A. baumannii in this isolate.
In conclusion, this is the ﬁrst report of the
identiﬁcation of the MBL VIM-4 determinant in
Acinetobacter spp., which emphasises the fact that
carbapenem-hydrolysing class D b-lactamases are
not the sole factor leading to the emergence of
resistance to carbapenems in this genus. Interest-
ingly, blaVIM-4 was identiﬁed in a non-A. bauman-
nii isolate, thereby indicating that non-clinically
signiﬁcant Gram-negative species may also be
reservoirs of MBL-encoding genes. Also notewor-
thy is the occurrence of VIM-4 in Acinetobacter in a
country in which VIM-4 has been reported pre-
viously in P. aeruginosa. Thus, as observed previ-
ously with blaVIM-1 in Greece, this is yet another
example of resistance genes known to be wide-
spread in P. aeruginosa apparently crossing the
species barrier to reach Acinetobacter spp.
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Fig. 1. (A) Pulsed-ﬁeld gel electrophoresis proﬁle of
I-CeuI-digested whole-cell DNA of Acinetobacter genomo-
species 16 isolate 154. Southern hybridization was per-
formed with a 16S–23S rRNA gene-speciﬁc probe (B) and a
blaVIM-speciﬁc internal probe (C). The arrow indicates the
band for which a co-hybridisation signal was obtained.
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